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Dopaminergic (DA) neurons have been implicated as key targets in neurological
disorders, notably those involving locomotor impairment, and are considered
to be highly vulnerable to mitochondrial dysfunction, a common feature of such
diseases. Here we investigated a Drosophila model of locomotor disorders in
which functional impairment is brought about by pan-neuronal RNAi knockdown
of subunit COX7A of cytochrome oxidase (COX). Despite minimal neuronal loss
by apoptosis, the expression and activity of tyrosine hydroxylase was decreased
by half. Surprisingly, COX7A knockdown specifically targeted to DA neurons did
not produce locomotor defect. Instead, using various drivers, we found that
COX7A knockdown in specific groups of cholinergic and glutamatergic neurons
underlay the phenotype. Based on our main finding, the vulnerability of DA
neurons to mitochondrial dysfunction as a cause of impaired locomotion in other
organisms, including mammals, warrants detailed investigation.
INTRODUCTION
Mitochondrial stress, whether resulting from impaired respiration, oxidative damage, or defective protein
quality control, has been proposed as a major underlying process in neurological diseases, notably those
where locomotion is impaired, such as Parkinson’s disease (PD; recently reviewed by Ge et al., 2020). The
main pathological target in such diseases is dopaminergic (DA) neurons (Lees et al., 2009), and these are
believed to be specifically sensitive to mitochondrial dysfunction (Bose and Beal, 2016), whether induced
by toxins (Terron et al., 2018), genetic predisposition (Deng et al., 2018), or somatic accumulation of genetic
damage, such as to mitochondrial DNA (Bender et al., 2006; Kraytsberg et al., 2006). Many questions
remain open, as to why DA neurons are especially sensitive to mitochondrial dysfunction and how this re-
sults in loss of function and eventually produces disease.
The fruit fly Drosophila melanogaster has emerged as a useful animal model for studying pathological pro-
cesses and possible treatment options for neurological disorders (Jeibmann and Paulus, 2009; McGurk
et al., 2015), including the role of mitochondria (Guo, 2012). DA neurons in Drosophila have been impli-
cated in a number of behavioral processes, including feeding, sleep, and locomotion, and fly models of lo-
comotor dysfunction strongly support a role for mitochondrial stress in the phenotype.
In the Drosophila brain there are rather few DA neurons, mostly located in anatomically distinct clusters
specified during embryogenesis (Hartenstein et al., 2017). Because of their functional and anatomical sim-
ilarities with DA neurons in vertebrates, they are of great interest in the fields of neurodegeneration and
other neurological disorders, both movement related and psychiatric (White et al., 2010). In addition to
the panoply of genetic tools available to probe cellular and physiological processes in the fly, a number
of simple, quantifiable behavioral paradigms are well established in Drosophila. Prominent among them
is the negative geotaxis (climbing) assay, which has been widely used to measure locomotor competence
in adults. It is frequently considered a marker for neurodegeneration, especially when used to score the
effects of manipulating genes implicated in human neurodegenerative disease (Fernius et al., 2017). These
include, for example, the Alzheimer-associated beta-amyloid peptide (Marcora et al., 2014), the familial PD
gene Pink1 (Guo, 2012), or theDrosophila homologue of FUS (cabeza), implicated in one form of ALS (Frick-
enhaus et al., 2015).iScience 23, 101362, August 21, 2020 ª 2020 The Author(s).
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ArticleIn a previous study, we observed that pan-neuronal RNAi-mediated knockdown of various different sub-
units of cytochrome oxidase (COX, respiratory complex IV, cIV), the terminal enzyme of the mitochondrial
respiratory chain, results in a severe locomotor impairment as measured by the negative geotaxis assay
(Kemppainen et al., 2014). The phenotype was most severe when ‘‘core’’ subunits of the complex, such
as COX4, were targeted, with all flies dying at the early larval stages. However, when peripheral subunit
COX7A was targeted specifically, flies generally died as pupae, and even eclosed as adults if COX7A
knockdown was confined to neurons, or if the alternative oxidase (AOX) from Ciona intestinalis was ex-
pressed to provide a metabolic bypass for cIV (Kemppainen et al., 2014; Andjelkovic et al., 2015).
The functional role of the COX7A subunit is not fully known, although it is clearly required for cIV assembly
and full COX activity (reviewed by Mansilla et al., 2018). One mammalian paralog, Scafi (also known as
COX7A-related protein, COX7RP, or COX7AL2), has been implicated in the formation of respiratory super-
complexes (Lapuente-Brun et al., 2013; Ikeda et al., 2013).
In addition to the canonical COX7A gene, the Drosophila genome has two homologs thereof, namely,
COX7AL, expressed only in testis, and CG34172, expressed mainly in adult carcass and other muscle-con-
taining tissues (heart, gut), with all three showing greater similarity to the twomammalian COX7A isoforms,
COX7A1 (heart) and COX7A2 (liver) than to Scafi, and therefore considered as standard subunits of cIV.
Given that CG34172 is only minimally expressed in the nervous system, combined with the specificity of
available GAL4 drivers, this affords an opportunity to study the biological effects of neural knockdown
of COX without having a major effect on muscle or any other tissues.
Given the prevailing view in the field that DA neurons are especially vulnerable to mitochondrial dysfunc-
tion, we set out to investigate how COX deficiency impacts them in the fly, taking as our starting point the
previous observations on pan-neuronal COX7A knockdown (Kemppainen et al., 2014; Andjelkovic et al.,
2015). Although we observed a clear decrease in the level of the key DA biosynthetic enzyme tyrosine hy-
droxylase (TH), these effects were found to be secondary in nature. Although such findings cannot be
directly translated to mammals, they highlight the need to re-examine thoroughly the link between mito-
chondrial dysfunction, DA neuron degeneration, and locomotor impairment in other contexts.RESULTS
Pan-Neuronal Knockdown of COX7A Decreases TH Expression in DA Neurons
We first confirmed the effectiveness of RNAi directed against COX7A, using VDRC (RRID:SCR_013805) line
106661 plus the pan-neuronal elav-GAL4C155 driver, in combination with UAS-Dcr2 to potentiate its effects
on locomotion. The driver and UAS-Dcr-2 alone produced no locomotor impairment (Andjelkovic et al.,
2015), so this was included as a control in the experiments to profile the effects of knockdown. Western
blots showed that pan-neuronal COX7A knockdown resulted in an 50% decrease in the amount of
COX4 protein in fly heads (Figure S1A), a proxy for assembled cIV, and a similar decrease in respiratory
function (Figure S1B), showing clearly that the phenotype obtained is associated with mitochondrial
dysfunction.
Previous studies (Kemppainen et al., 2014) found no gross anatomical abnormalities from COX knockdown
during development, implying that it does not result in substantial cell death. To profile ongoing cell death
in the brains of flies with pan-neuronal COX7A knockdown, we used two approaches. TUNEL staining re-
vealed a very low number of apoptotic cells, despite strong signals in the positive control (Figure S1C).
However, although low, the number of TUNEL-positive cells in knockdown brains was significantly higher
than in controls (Figure S2A) and included both neuronal and glial cells (Figure S2B). Using the Apoliner
reporter system (Bardet et al., 2008), in which apoptotic cells are marked by the nuclear translocation of
GFP, we observed only very few such examples (Figures S3 and S4). We also observed no increase in signal
compared with controls, when knockdown brains were stained with dihydroethidium (Figure S5) as a crude
marker for superoxide production.
Pan-neuronal COX7A knockdown produced no obvious difference in the number of TH-positive neurons
but nevertheless revealed a marked decrease in TH signal (Figure 1A). To quantify the effect, we focused
on a specific cluster of DA neurons, the PAL (protocerebral anterior lateral) cluster, avoiding issues arising
from the differing signal intensities from different such clusters (Mao and Davis, 2009). The average signal
intensity, whether computed per brain or per cell (Figure 1B), showed a significant (50%) decrease in2 iScience 23, 101362, August 21, 2020
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Figure 1. Pan-Neuronal Knockdown of COX7A Leads to TH Deficiency
(A) Immunohistochemistry for TH on brains from male flies with and without pan-neuronal knockdown of COX7A
(representative images). Genotypes as follows–control (designated as elav-GAL4>landing vector in B and C): elav-
GAL4C155, UAS-Dcr-2 / Y; P{attP, y+, w3}/+. elav-GAL4>COX7A KD: elav-GAL4C155, UAS-Dcr-2 / Y; UAS-RNAiCOX7A / +,
where UAS-RNAiCOX7A denotes the dsRNA-encoding insertion in VDRC line 106661. Rabbit anti-TH antibody, 1:500, used
with Alexa 488 goat anti-rabbit secondary antibody, 1:500. Scale bars, 100 mm. Note that batches of control and
knockdown brains were processed in parallel using the same reagents. Counterstaining for Elav (Figure S6) indicated that
low TH signal was not due to a general issue with antibody penetration. The range of staining intensities likely reflects
both technical variability in sample preparation and visualization, as well as biological variation.
(B) Quantitation of TH signal from immunohistochemistry on multiple specimens of the types shown in (A). Signal was
quantitated in dopaminergic neurons of the PAL (protocerebral anterior lateral) cluster and plotted as mean signal
intensity (GSD) for each brain (left-hand columns: elav-GAL4>landing vector controls, n = 4, elav-GAL4>COX7A KD, n =
8) or for each analyzed cell considered as a separate data point (right-hand columns: elav-GAL4>landing vector, n = 11,
elav-GAL4>COX7A KD, n = 27). Note that all flies also carried UAS-Dcr-2. The PAL cluster was selected, being easily
identified, close to the anterior surface of the brain, and comprising only a few cells.
(C) TH activity from extracts of female fly heads of the indicated genotypes: elav-GAL4>UAS-Dcr-2 only – elav-GAL4C155,
UAS-Dcr2, elav-GAL4>landing vector – elav-GAL4C155, UAS-Dcr-2; P{attP, y+, w3} / + and elav-GAL4>COX7A KD – elav-
GAL4C155, UAS-Dcr-2; UAS-RNAiCOX7A/+.
Significant differences (Student’s t test or, where more than two classes were compared, one-way ANOVAwith Tukey post
hoc HSD test) denoted as *, **, and ***, representing p < 0.05, 0.01, and 0.001, respectively. See also Figures S1–S5 for
validation of knockdown and its effects and Figure S6 for validation of immunohistochemistry.
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Articleknockdown brains. TH activity, measured in protein extracts from isolated heads, showed a similar
decrease (Figure 1C). Decreased TH activity in knockdown brains is consistent with a specific effect on
DA neurons.Locomotor Defect Is Caused by COX7A Knockdown in Specific Groups of Neurons
To test whether DA neurons are the functionally relevant target in generating locomotor defect by COX7A
knockdown, we used the drivers TH-GAL4, which selectively targets DA neurons, Ddc-GAL4, which targets
both serotonergic and DA neurons, and TRH-GAL4, specific for serotonergic neurons. To ensure effective
knockdown, we included UAS-Dcr-2 in all knockdown experiments. As negative controls we combined
UAS-Dcr-2 with each driver (except for elav-GAL4, which was included here as a positive control). Neither
of the DA drivers (nor the one targeting only serotonergic neurons) gave a significant locomotor defect
(Figure 2A). Using a wider selection of drivers (Figure 2B), we observed a significant locomotor defect
when COX7A knockdown was driven by Cha-GAL4 (cholinergic neurons) or by OK371 (glutamatergic neu-
rons) but not by acj6-GAL4 (Figures 2B and 3A), targeting a restricted group of cholinergic neurons (Lee
and Salvaterra, 2002). Drivers targeting GABAergic or octopaminergic neurons or glia also had no effect
on locomotor activity (Figure 2B).iScience 23, 101362, August 21, 2020 3
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Figure 2. Locomotor Impairment Is due to COX7AKnockdown in Neurons of Specific Neurotransmitter Identities
Climbing index for COX7A-KD flies derived by crossing the indicated GAL4 driver or control males (homozygous or
balanced, as indicated in Transparent Methods) to UAS-RNAiCOX7A; UAS-Dcr-2 females or (A, controls) to UAS-Dcr-2
females without the RNAi construct.
(A) Boxplots indicate medians (bold lines), 25th and 75th percentiles (box limits), and 1.5 times the interquartile range
(Tukey-style whiskers, truncated where they would cross the zero or maximum lines) for batches of 10 virgin female flies.
Colored dots represent individual data points for each batch (means of three tests) as indicated. Significant differences
(one-way ANOVA with Tukey post hoc HSD test), indicated as ***, p < 0.001 for comparison with all other data classes, ns,
p > 0.05 for the pairwise comparisons indicated. Other comparisons omitted for clarity. Note that the elav-GAL4 driver
was included here as a positive control.
(B) Means G SD (nR 4, except for repo-GAL4, n = 3) for batches of five virgin female flies. Statistical analysis (one-way
ANOVA with Tukey post hoc HSD test; significant differences indicated by red and blue bars, denoting p < 0.05 and p <
0.01, respectively. For repeat experiments usingCha-GAL4 andOK371 drivers, alongsideUAS-Dcr-2 controls, see Figures
3B and 3C. Note that TH-GAL4 drives expression only poorly, if at all, in a small subset of DA neurons that are, conversely,
targeted by Ddc-GAL4 (Riemensperger et al., 2013); both drivers are therefore needed to cover all DA neurons. Based on
GFP controls, drivers were active in cells of the predicted identity (Figures S7–S9), although the TRH-GAL4 driver did drive
expression in a small number of TH-positive (i.e., DA) neurons (Figure S9B). Effects in DA neurons were not simply delayed
(see Figure S10).
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(see Figures S11–S13). We therefore proceeded to test additional drivers, incorporating only fragments of
the ChAT gene, to identify more restricted subsets of cholinergic neurons responsible for the locomotor
phenotype and confirm their neurotransmitter identities. Given the large number of neurons targeted by
OK371 (Figure S14), we took a similar approach to narrow down the susceptible glutamatergic neurons,
using drivers incorporating fragments from the VGlut gene. We identified strong candidates from both
sets (Figure 3A) and confirmed them against UAS-Dcr-2 controls (Figures 3B and 3C). In summary, the lo-
comotor defect produced by neuronal knockdown of COX7A is dependent on restricted subsets of cholin-
ergic and glutamatergic neurons, rather than on DA neurons as initially assumed.
Several Largely Non-overlapping Sets of Neurons Are Susceptible to COX7A Knockdown
For further study we selected the two cholinergic (R55A05 and R59E04) and the two glutamatergic drivers
(R52A01 and R51C09) giving the strongest locomotor impairment. The expression patterns of these drivers
are already known and were verified using fluorescent reporters before proceeding. Expression driven by
the cholinergic driver R55A05 labeled a number of specific brain structures (Figures 4A and 4B), with wide-
spread colocalization with ChAT, although in some brain regions the ChAT signal was very weak. There was
no convincing colocalization with TH or other specific neural markers (see Figures S16 and S17). The second
cholinergic driver (R59E04) exhibited an almost completely distinct expression pattern (Figures 4C and
S18), with variable and incomplete colocalization with ChAT (Figures 4C and S19), and no overlap with
TH (see Figure S20).
The two selected glutamatergic drivers showed limited expression in the brain (Figures 5 and 6), most
prominently in the optic lobe (Figures 5A and 6A). Because motoneurons are glutamatergic in Drosophila,
we investigated whether they were targets of either driver, by examining the subcuticular neurons of the
larval PNS, where motoneurons are easily distinguished. R51C09 directed expression in a pair of prominent4 iScience 23, 101362, August 21, 2020
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Figure 3. Locomotor Impairment due to COX7A Knockdown in Specific Sub-groups of Cholinergic and
Glutamatergic Neurons
Climbing index for COX7A-KD flies derived by crossing the indicated GAL4 drivers, from the FlyLight (Jenett et al., 2012)
and Vienna Tiles collections (Tirian and Dickson, 2017), or control males to UAS-RNAiCOX7A; UAS-Dcr-2 females or (B,
controls) to UAS-Dcr-2 females without the RNAi construct.
(A) MeansG SD (nR 4) for batches of 10 virgin female flies. Significant differences (one-way ANOVA with Tukey post hoc
HSD test) indicated as *, **, and ***, denoting p < 0.05, 0.01, and 0.001, respectively, in comparison with controls. Other
comparisons omitted for clarity. (i) and (ii) represent separate series of experiments for cholinergic and glutamatergic
drivers, as indicated. As denoted by the dotted line, for logistical reasons, experiments with the cholinergic VT043784
driver were performed and analyzed together with those using the glutamatergic drivers shown in (ii).
(B and C) Boxplots for selected (B) cholinergic and (C) glutamatergic drivers, using the same conventions and statistical
analyses as in Figure 2A.
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Articleaxons, repeating in each hemisegment of the trunk (Figure 5C). Their cell bodies were absent, consistent
with their being motoneurons, since motoneuron cell bodies lie in the ventral nerve cord, which was
removed in the dissection of the larvae. R52A01 also directed expression in prominent subcuticular neurons
repeating in each hemisegment (Figure 6C). As the cell bodies of these neurons were present in the
dissected larvae, they cannot be motoneurons and are almost certainly sensory neurons. Using a dual-re-
porter system we confirmed that there was very little overlap in the brain-expression patterns of the two
selected cholinergic drivers or the two selected glutamatergic drivers (see Figures S23 and S24). We
conclude that locomotor impairment can be brought about by mitochondrial dysfunction in any of several
largely independent sets of neurons.
Only a Minor Fraction of COX7A Knockdown-Sensitive and DA Neurons Interact Directly
Based on the above findings, the neurons vulnerable to mitochondrial dysfunction are not dopaminergic,
even though TH was depleted by pan-neuronal knockdown of COX7A. This raises the possibility that DA
neurons and those sensitive to COX7A knockdown are part of the same neural circuits controlling
locomotion. Consistent with this, dendritic projections from sensitive cholinergic neurons are found in
the same areas of the brain as those from TH-positive neurons (Figures S25 and S26), although this
does not demonstrate direct interaction. Moreover, using the trans-Tango reporter system (Talay
et al., 2017), we found only a very low proportion of TH-positive neurons connected post-synaptically
to those targeted by the R55A05 driver (Figure 7, Figures S27–S31, Video S1), and this did not include
any of the prominent clusters of DA neurons where the loss of TH signal was quantified in earlier exper-
iments. Any connections between the cholinergic neurons targeted by this driver and major groups of
DA neurons involved in locomotor functions must therefore be indirect.iScience 23, 101362, August 21, 2020 5
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Figure 4. Neuronal Targets of GAL4 Drivers R55A05 and R59E04
Immunohistochemistry of brains from individual flies expressing mCD8 reporters under the control of the GAL4 drivers
indicated.
(A) Single optical section co-stained for CD8 (rat anti-CD8, 1:200, followed by Alexa 568 goat anti-rat) and ChAT (mouse
anti-ChAT, 1:100, followed by Alexa 488 goat anti-mouse). Scale bar, 100 mm. For equivalent maximum intensity
projection of the whole brain stained for CD8, see Figure S15.
(B) Highermagnificationof some specificbrain regions co-stained forGFP (rabbit anti-GFP, 1:1,000, followedbyAlexa 488goat
anti-rabbit) andChAT (mouse anti-ChAT, 1:100, followed byAlexa 647 goat anti-mouse). Scale bar, 20 mm. These aremaximum
intensity projections compiled from a few adjacent optical sections, sufficient to reveal the shapes of the co-stained structures.
The fourth structure (marked ‘‘[unclear]’’) shows a structure thatwewere unable to identify with confidence fromVirtual Fly Brain
(v2.virtualflybrain.org).Note that, becauseoverlap appeared so extensive in the first experiment (Figure 4A), we here combined
a green and a far-red fluor to minimize any possible bleeding between channels.
(C) Maximum intensity projection stained for GFP (rat anti-CD8, 1:200, followed by Alexa 647 goat anti-rat) and for ChAT
(mouse anti-ChAT, 1:100, followed by Alexa 488 goat anti-mouse). Scale bar, 100 mm. See also Figures S16–S20: note that
these two drivers targeted largely non-overlapping sets of cholinergic neurons, whereas neither was active in DA neurons.
ll
OPEN ACCESS
iScience
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Although we found no evidence of widespread cell death in the brains of adult COX7A knockdown flies, this
does not exclude death of vulnerable neurons during development. To test this, we set up crosses using
males from each of the selected driver lines mated with balanced females expressing Hid, a potent inducer
of apoptosis (Sandu et al., 2010), under GAL4 control (see Transparent Methods). In the case of all four
selected drivers, all eclosing progeny carried the balancer markers. Therefore, the death of the targeted
cells is developmentally lethal, excluding widespread neuronal death as the mechanism by which
COX7A knockdown results in locomotor impairment.
TH Deficiency Does Not Correlate with Locomotor Defect in COX7A Knockdown Flies
Given that the connections between targeted and DA neurons appear to be mostly indirect, we tested
whether the TH deficiency produced by pan-neuronal COX7A knockdown could be recapitulated by tar-
geting COX7A knockdown to specific groups of neurons, using the selected drivers. The R55A05 GAL4
driver gave, at most, a modest, diminution of TH signal (Figure 8), whereas that produced by the R59E04
driver, with a weaker locomotor effect, was generally more pronounced (Figure 8). Similar findings were
obtained using the glutamatergic drivers (Figure 9). These findings imply that TH deficiency and impaired6 iScience 23, 101362, August 21, 2020
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Figure 5. Neuronal Targets of GAL4 Driver R51C09
Immunohistochemistry of (A) whole brains and (B) portion of optic lobes from adult females, and (C) larval subcuticular
neurons, from Drosophila expressing mCD8-GFP under the control of GAL4 driver R51C09.
(A and B) Single optical sections of samples co-stained for CD8 and VGlut. Scale bar, 100 mm in (A) and 20 mm in (B).
(C) Maximum intensity projections of samples co-stained for GFP and the microtubule-binding protein Futsch. (i) Low
magnification, anterior to the top, dorsal midline in themiddle. (ii) Higher magnification, dorsal side to the top, anterior to
left. Scale bars, 200 mm. Note that there was no colocalization with GABA or TH (Figure S21).
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mental in the behavioral phenotype.
DISCUSSION
In this study we showed that several groups of susceptible cholinergic and glutamatergic neurons, but not
dopaminergic (DA) neurons, underlie the locomotor impairment brought about by RNAi-mediated knock-
down of a subunit of cytochrome c oxidase in the Drosophila nervous system. This challenges the widely
held assumption that DA neurons are key targets of mitochondrial dysfunction, leading to impaired loco-
motor function, at least in the fly.
Mitochondrial Dysfunction in Specific Cholinergic and Glutamatergic Neurons Is Instrumental
in Locomotor Impairment
Pan-cholinergic and pan-glutamatergic COX knockdown both produced a severe locomotor phenotype.
We used drivers targeting much more restricted subsets of neurons to narrow down this vulnerability
and exclude cells with other neurotransmitter identities. However, the two cholinergic drivers giving signif-
icant locomotor impairment had almost completely non-overlapping expression profiles, with the one
showing the stronger effects (R55A05) expressed in numerous brain regions. Thus, it is not yet possible
to say which such regions are the more critical. On the glutamatergic side, the two strongest drivers also
showed only partially overlapping expression patterns in the brain (Figures 5 and 6), with prominent expres-
sion also in different cells of the larval peripheral nervous system (PNS), one inmotoneurons (Figure 5C) and
the other in a subclass of sensory neurons (Figure 6C). Note also that COX7A knockdown driven by D42,
which targets at least some adult motoneurons (Yeh et al., 1995; Sanyal et al., 2003), gave no such pheno-
type (Figure 3A). Locomotor impairment may therefore be due to mitochondrial dysfunction in a variety of
specific cells in the brain, PNS or both, in diverse combinations.
Our study illustrates the limitations of the widely used negative geotaxis assay, in that a similar locomotor
impairment can be independently produced by a primary defect in any of a number of distinct subsets ofiScience 23, 101362, August 21, 2020 7
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Figure 6. Neuronal Targets of GAL4 Driver R52A01
Immunohistochemistry of (A) whole brains and (B) selected brain areas from adult females, and (C) larval subcuticular
neurons, from Drosophila expressing mCD8-GFP under the control of GAL4 driver R52A01.
(A and B) Single optical sections of samples co-stained for CD8 and VGlut. Scale bar, 100 mm in (A) and 20 mm in (B).
(C) Maximum intensity projections of samples co-stained for GFP and the microtubule-binding protein Futsch. (i) Low
magnification, anterior to the top, dorsal midline in themiddle. (ii) Higher magnification, dorsal side to the top, anterior to
left. Scale bars, 100 mm. Note that there was no colocalization with GABA or TH (Figure S22).
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ular mechanism. Experiments using the assay should therefore be interpreted with caution. The current
study also prompts an analysis of a broader range of behavioral phenotypes in flies with neuronal COX
deficiency.Effects on DA Neurons
Ddc-GAL4 and TH-GAL4most strongly target different subsets of DA neurons (Riemensperger et al., 2013),
but neither was able to produce locomotor impairment when used to drive COX7A knockdown. This con-
trasts with the findings of Riemensperger et al. (2013), who found that the expression of the PD-associated
human a-synuclein A30P variant produced a locomotor defect when expressed using the Ddc-GAL4 but
not the TH-GAL4 (or TRH-GAL4) drivers. Although we cannot exclude that simultaneous COX deficiency
in both groups of DA neurons is required to produce locomotor impairment, we did not detect TH-positive
cells among those targeted by any of the four drivers that did produce the phenotype. Therefore, it is highly
unlikely that COX deficiency in DA neurons contributes cell-autonomously to a locomotor phenotype,
except perhaps in very aged flies.
Pan-neuronal COX7A knockdown did lead to a deficiency of TH, but its relationship to locomotor impair-
ment is unclear. Although a non-cell-autonomous impairment of DA neuron function is a plausible expla-
nation for our findings, TH deficiencymight also be a secondary effect of dysfunction in relevant circuits that
is not instrumental in the locomotor phenotype. Consistent with this, the individual drivers tested had vary-
ing andmore subtle effects on TH levels (Figures 8 and 9). The two phenotypes (TH deficiency and impaired
locomotion) are thus not tightly correlated.8 iScience 23, 101362, August 21, 2020
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Figure 7. A Minor Fraction of R55A05 Post-synaptic Neurons Are Dopaminergic
Immunohistochemistry for TH (green, 1:500) and RFP (magenta) from brain of a female fly post-synaptically expressing
RFP under the control of trans-Tango, driven by R55A05. Genotype: UAS-myrGFP, QUAS-mtdTomato-3xHA / +; trans-
Tango / +; R55A05-GAL4 / +. Zoomed images from individual optical sections; scale bar, 20 mm (all images to same scale).
Images optimized for brightness and contrast but not manipulated in any other way. Overlap signals (white, pale
magenta, and pale green, panels viii, x–xii) represent only a small minority of cells, not including (panels i–vi) the major
clusters of DA neurons. Nevertheless, strong post-synaptic signals are seen both in TH-negative cell bodies (panels ii, iii,
viii, ix) and in regions with abundant neurites (panels vi–viii, xii). For side-by-side comparisons of signals from the separate
channels see Figures S27–S29. For the whole brain images from which these panels were derived, see Video S1 and
Figures S30 and S31.
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We were unable to detect a prominent signature of cell death associated with pan-neuronal knockdown of
COX7A. Moreover, there was no obvious difference in the number of PAL neurons, in contrast to the find-
ings of Humphrey et al. (2012). Although we might have missed a very small decrease in the number of DA
neurons, it is unlikely to account for the severe locomotor impairment produced. Although long-term loss
of inputs to these neurons may result in their eventual loss, our data implicate COX deficiency in other
group of neurons, not DA cell death, as the underlying cause of locomotor impairment.
Comparison with Previous Studies of Mitochondrial Dysfunction in DA Neurons
Our findings contrast with previous reports of progressive DA-cell loss and impaired locomotion, when a
mitochondrial insult was targeted to DA neurons using the same TH-GAL4 driver as here (Humphrey et al.,
2012), involving RNAi against the catalytic subunit of the mitochondrial DNA polymerase, Polg (tamas).
Conversely, applying Cha-GAL4 produced no such phenotype, whereas in the current report, RNAi against
a subunit of cIV produced an opposite result. The discrepancy with our findings could have various expla-
nations, which need to be explored in future studies.
First, the phenotype described by Humphrey et al. (2012) is a progressive one with late onset. tamas knock-
down flies initially showed only a very mild degree of locomotor impairment, but that steadily worsened
during adult life, whereas COX7A knockdown had dramatic (but stable) effects in young adult flies. The
two phenotypes studied, i.e., age-related neurodegeneration and developmental locomotor impairment,
are fundamentally different and may be produced by entirely different mechanisms. Note that most cases
of heritable mitochondrial dysfunction affecting the CNS in humans manifest in infancy and are often fatal
within the first weeks or months of life (Gorman et al., 2016).iScience 23, 101362, August 21, 2020 9
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Figure 8. TH Deficiency Resulting from COX7A Knockdown in Subsets of Cholinergic Neurons
Immunohistochemistry for TH (1:500) in brains from flies with COX7A knockdown or controls with only Dcr-2
overexpression, as indicated, using the GAL4 drivers shown (maximum intensity projections). Genotypes – Dcr-2 only: +;
R55A05-GAL4 (or R59E04-GAL4)/UAS-Dcr-2, COX7A-KD: UAS-RNAiCOX7A / +; R55A05-GAL4 (or R59E04-GAL4)/UAS-Dcr-
2. Scale bars, 100 mm. Contrast and brightness have been similarly adjusted in each image, giving uniform background
fluorescence. See Figures S32–S35 for these and images of other brains from flies of the same genotypes, alongside
images showing counter-stain for Elav.
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clear but isolated deficiency of cytochrome oxidase, whereas the former should produce mtDNA depletion,
affecting all four enzymatic components of the oxidative phosphorylation (OXPHOS) system that are dependent
onmtDNA-encoded gene products. Different classes of neuronmay have quite distinct susceptibilities to these
different metabolic stresses. AOX expression in the Polgmodel (Humphrey et al., 2012) also had much less dra-
matic effects than in the COX7A model (Kemppainen et al., 2014; Andjelkovic et al., 2015).
Finally, in a different study (Bahhir et al., 2019), stress imposed upon mtDNA by the ubiquitous expression
of a bacterial type I restriction endonuclease produced a range of metabolic abnormalities unrelated to
OXPHOS, including decreased levels of dopamine, and accompanying behavioral changes, notably in
feeding. Dietary supplementation with L-DOPA restored wild-type feeding behavior and delayed the onset
of lethality in the model. Although the detailed mechanism of the effect remains to be elucidated, mito-
chondrial dysfunction and its effects on DA-producing cells clearly should not be considered as a single,
‘‘all or none’’ phenomenon.
Possible Relevance to Neurological Disease
Owing to the involvement of mitochondrial gene products and toxin targets in human neurological
disease, combined with the evidence for DA neuron degeneration as a pathomechanism in progressive lo-
comotor disorders, it is widely assumed that DA neurons are particularly vulnerable to mitochondrial
dysfunction. Although our study may not be directly translatable to the human context, relates to only
one component of the OXPHOS system (cIV), and concerns a developmental rather than a degenerative
phenotype, neurological involvement is a common feature of early-onset mitochondrial disease (Gorman
et al., 2016). Our findings indicate that the direct neuronal targets of mitochondrial dysfunction leading to
locomotor impairment, at least in early-onset disease, may not be DA neurons, but some other class of neu-
ral cells, with any effects on DA neurons being secondary to the underlying defect. Mitochondrial dysfunc-
tion has also been widely proposed as an instrumental factor in a variety of neurodegenerative diseases
(Smith et al., 2019; Lim et al., 2020). Neuronal classes other than DA neurons have recently been implicated
in neurodegenerative disease in humans (Liu, 2020). Our findings provide a possible model whereby mito-
chondrial dysfunction in such cells might be an underlying factor in the pathology, operating long before
overt neurodegeneration manifests.10 iScience 23, 101362, August 21, 2020
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Figure 9. TH Deficiency Resulting from COX7A Knockdown in Subsets of Glutamatergic Neurons
Immunohistochemistry for TH (1:500) in brains from flies with COX7A knockdown or controls with only Dcr-2
overexpression, as indicated, using the GAL4 drivers shown (maximum intensity projections). Genotypes – Dcr-2 only: +;
R52A01-GAL4 (or R51C09-GAL4)/UAS-Dcr-2, COX7A-KD: UAS-RNAiCOX7A / +; R52A01-GAL4 (or R51C09-GAL4)/UAS-
Dcr-2. Scale bars, 100 mm. Contrast and brightness have been similarly adjusted in each image, giving uniform
background fluorescence. See Figures S36–S39 for these and images of brains from flies of the same genotypes,
alongside images showing counterstain for Elav.
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ArticleDrosophila has proven to be a useful model for understanding fundamental biological processes in ani-
mals, such as the axial patterning of the nervous system (Estacio-Go´mez and Dı´az-Benjumea, 2014) or circa-
dian behavior (Dubowy and Sehgal, 2017). In this light, and considering the conserved metabolism and
function of DA neurons, it would be appropriate to re-examine this vulnerability to mitochondrial dysfunc-
tion of DA and other classes of neuron in other organisms, including mammals, and to test the effects of
different types of mitochondrial insult, bearing in mind that the neuroanatomical differences (e.g., in
size) between fly and mammalian brains may dictate a distinct outcome.Limitations of the Study
As discussed above, the study was conducted on a single model organism (Drosophila melanogaster), us-
ing only one, albeit common, type of mitochondrial dysfunction, COX deficiency, here resulting from
knockdown of a COX subunit. It focused on a single behavioral readout, locomotor impairment, and
was concerned only with an intrinsic, developmentally determined, neural phenotype, rather than with
age-related degeneration. Finally, although excluding a widely assumed mechanism whereby mitochon-
drial dysfunction results in locomotor impairment (i.e., a cell-autonomous effect in DA neurons), it leaves
open the molecular mechanism(s) that do operate here.Resource Availability
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by
the Lead Contact, Howard T. Jacobs (howard.jacobs@tuni.fi).
Materials Availability
The study did not generate any new, unique reagents. All materials used in the work were sourced from
public or commercial resources (Drosophila stock centers, antibody suppliers, manufacturers of standard
laboratory equipment and reagents), as described under Transparent Methods (see Supplemental Infor-
mation). If any such reagents or strains should become unavailable from these sources, the authors will
be happy to assist in procuring them elsewhere, as far as they are able.iScience 23, 101362, August 21, 2020 11
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ArticleData and Code Availability
This study did not generate or use any new datasets or machine code. All of the primary experimental data
used in compiling this paper are included in the figures and Supplemental Information. For images pre-
sented here as maximum projections, the original image stacks are available upon request, although
they do not provide any salient additional information relevant to the study.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2020.101362.
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TRANSPARENT METHODS
Drosophila strains and culture
Drosophila strains used in the study, and their sources, are summarized in Table S1. Flies were
maintained in standard high-sugar medium (Kemppainen et al., 2016) on a 12 h light/dark cycle
at 25 °C. Crosses were generally implemented in triplicate, with flies tipped to new vials on three
successive days after mating.
Repetitive iterative negative geotaxis (RING) assay
Eggs from parents crossed two days earlier were collected over three consecutive days, and
cultured at 25 °C until eclosion. Virgin female progeny were then kept in food vials at 25 °C
until day 3, when they were sorted into batches of 10 flies and maintained at 25 °C for a further 2
days. On day 5, flies were tipped from vials to 50 ml Falcon tubes without the use of CO2
(Bartholomew et al., 2015). Up to six Falcon tubes were placed in rows as described (Nichols et
al., 2012). After a 10 min waiting period, flies were tipped down and their subsequent behavior
recorded using a DFK 21AF04 camera (The Imaging Source, Bremen, Germany) and Media
Recorder 2 software (Noldus, Wageningen, Netherlands). The climbing index (Kemppainen et
al., 2014) for each vial was manually calculated from recordings as the mean number of flies
which climbed 6 cm in 10 s in three trials. Climbing indices from different genotypes were
compared by one-way ANOVA with Tukey post hoc HSD test. Box plots were drawn with
BoxPlotR (boxplot.tyerslab.com), with Tukey-style whiskers (Krzywinski and Altman, 2014).
Evaluation of apoptotic phenotypes
To determine the phenotype produced by inducing cell-death during development in a specific
set of cells defined by a given driver, crosses were set up using males from the driver in question
(either homozygous or combined with a genetically marked balancer chromosome) with
balanced females of genotype UAS-Stinger, UAS-hid / CyO. Hid being a potent inducer of the
intrinsic pathway of apoptosis (Sandu et al., 2010), this approach allowed the extent of apoptosis
to be profiled in surviving non-balancer progeny by the absence of GFP expression in the target
cells, and this correlated with any observed phenotype(s).
Lifespan measurements
Flies were mated for 2 days at room temperature. Eggs were collected into fresh vials and
cultured to eclosion at 25 °C. Eclosed females were transferred to fresh vials (5 vials per group,
20 flies per vial) and tipped to new vials every 2-3 days until no live flies remained. At each
transfer, the number of dead flies was recorded, from which a median lifespan for each vial was
calculated.
Western blotting
Flies were anaesthetized and decapitated on ice and heads were snap-frozen for storage at -80
°C. Protein extracts were prepared from batches of 30 fly heads essentially as described by
Fernandez-Ayala et al. (2009), by homogenization using a disposable plastic pestle, in PBS
containing 1.5% (w/v) Triton X-100 plus, per 25 ml, one cOmpleteTM EDTA-free Protease
Inhibitor Cocktail tablet (Roche). After incubation at room temperature for 5 min, samples were
centrifuged at 15,000 gmax for 10 min at room temperature, and supernatants transferred to fresh
tubes on ice. Protein concentrations were determined using the Bradford assay. After the addition
of an equal volume of SDS sample buffer (Laemmli 2× concentrate, Sigma-Aldrich), samples
were heated for 5 min at 100 °C, briefly centrifuged to remove particulates, and 20 μg of each
extract was loaded onto 18-well precast Any kDTM CriterionTM TGX Stain-FreeTM Protein Gels
(Bio-Rad), which were run and blotted as described (Andjelković et al., 2015). For detection of
ATP5A, α-actinin or GAPDH, blots were blocked in PBS-0.1% Tween (PBS-T) containing 5%
nonfat milk for 2 h then reacted overnight in the same buffer at 4 °C with primary antibody
(ATP5A: Abcam mouse monoclonal ab14748, 1:100,000; α-actinin: rabbit polyclonal C-20  sc-
7454-R, Santa Cruz Biotechnology, 1:7,000); GAPDH:  goat anti-GAPDH (C Terminus),
EB06377, Everest Biotech, 1:5,000) in PBS-T containing 5% nonfat milk at 4 °C, and washed
five times for 7 min in PBS-T. After incubation with secondary antibody (respectively,
peroxidase-labeled horse anti-mouse IgG (H+L), Vector Laboratories PI-2000, 1:10,000; rabbit
anti-goat IgG (H+L) HRP, Invitrogen, ThermoFisher Scientific 31402, 1:5,000 and peroxidase-
labeled goat anti-rabbit IgG (H+L), Vector Laboratories PI-1000, 1:10,000) for 1 h at room
temperature with further washes, blot signals were visualized by chemiluminescence (Immun
Star® Luminol enhancer and substrate, Bio-Rad) and documented both by X-ray film as well as
using a Bio-Rad ChemiDoc imager. For detection of Cox4 a similar procedure was used, except
that the blocking agent was 5% BSA instead of nonfat milk, primary antibody was Abcam
COXIV rabbit polyclonal, ab16056 (1:500) and secondary antibody was peroxidase-labeled goat
anti-rabbit IgG (1:10,000; PI-1000; Vector Laboratories).
Tyrosine hydroxylase (TH) assay
The activity of tyrosine hydroxylase was measured spectrophotometrically by the formation of
dopachrome, essentially as described earlier (Vermeer et al., 2013; Figueira et al., 2017). On the
day of eclosion, flies were snap-frozen in liquid nitrogen, vortexed for 20 s at 4 °C to separate fly
heads from bodies, then passed through a household sieve to collect the heads, which were stored
at -80 °C unless processed immediately. Heads were homogenized (1 mg per 10 μl, using a
plastic micropestle in a 1.5 ml Eppendorf tube) in ice-cold 50 mM Tris/HCl (pH 7.4) containing
0.1 mM phenylmethylsulfonyl fluoride (PMSF) and 0.1 mM dithiothreitol (DTT). TH activity
was assayed in a reaction mixture containing 100 mM HEPES/KOH (pH 7.0), 0.25 mM
tetrahydrobiopterin, 500 μM ferrous sulphate, 200 μM tyrosine, 100 μM sodium periodate, and
20-40 μg of supernatant protein, with a blank without protein extract used for background
subtraction. The reaction was monitored on a 2200 EnSpire plate reader (Perkin Elmer, US) at
475 nm for 30 min at 21 °C. Production of L-DOPA (L-3,4-dihydroxyphenylalanine) was
determined using a molar extinction coefficient for dopachrome of ε = 3700 M–1 cm–1. One unit
of tyrosine hydroxylase was defined as the amount of enzyme generating 1 μmol of L-DOPA per
min. In figures TH activity is expressed in international milliunits (mU) per milligram of soluble
protein (mU/mg protein). Protein content was measured by the Bradford (1976) method, with
bovine serum albumin (1-8 μg) used as a standard.
Respirometry
Respirometry was conducted essentially as previously (Andjelković et al., 2015), except using
batches of 50 freshly isolated heads from adult males instead of whole flies as source material,
and employing the O2K oxygraph instrument (Oroboros).
TUNEL assay
Cell death was profiled essentially as described by Ghosh et al. (2011) and Trunova and Giniger
(2012). Brains were dissected out in HL3.1 buffer (70 mM NaCl, 5 mM KCl, 20 mM MgCl2 , 10
mM NaHCO3 , 5 mM HEPES/NaOH, 115 mM sucrose, 5 mM trehalose, pH 7.2) and
immediately fixed in freshly made (Yalgin et al., 2011) ice-cold 4% paraformaldehyde in 0.1%
PBS (pH 7.2) for 20 min. After 3 washes for 20 min in 0.1% Triton X-100 in PBS (PBS-Tx),
brains were permeabilized in 100 mM citrate in PBS-Tx at 65 °C for 30 min, then subjected to
TUNEL reaction (In Situ Cell Death Detection Kit, fluorescein, Roche,  Cat. No. 11684795910)
for 3 h at 37 °C in the dark, followed by three washes for 20 min in PBS-Tx in the dark at room
temperature. Brains were then immunostained for fluorescein according to the protocol below
(see also Table S2). Positive control brains were made by subjecting fixed wild-type brains to
DNase I according to manufacturer’s instructions (ThermoFisher Scientific, Cat. no. #EN0521)
after the permeabilization step.
Immunohistochemistry
Brains were dissected out and fixed as for the TUNEL assay and blocked in freshly prepared 5%
bovine serum albumin (BSA; Sigma #A7906) for 20 min at room temperature. They were then
incubated in primary antibody solution (see Table S2), diluted in 5% BSA in PBS-Tx for ~36
hours at 4 °C, washed 3 times for 20 min in PBS-Tx, and incubated in secondary antibody
solution, diluted in 5% BSA in PBS-Tx for 2 nights at 4 °C (Wu and Luo, 2006). After 3 final
washes for 20 min in PBS-Tx, brains were mounted in 80% glycerol with coverslips raised by
double-sided tape. Dissection of larvae for immunohistochemistry was as previously reported
(Yalgin et al., 2011).
Image acquisition and analyses
Images from whole-mount brains were acquired confocally with a Zeiss LSM 700, and examined
manually using Fiji ImageJ software (RRID: SCR_003070). Quantitation of TH signal in
immunostained brains used images acquired with a Zeiss LSM 700 using a 10x objective. Brains
with the same genotype were imaged under the same coverslip. Up to four brains were scanned
at one time and then separated into separate TIFF files using ImageJ. Brightness was adjusted
using the same settings for all samples in a given experiment. To assess signals quantitatively,
the mean signal intensity of each cell body was measured from the image stack using the
'measure' function  of ImageJ. The background signal intensity was separately measured, then
subtracted from each ROI measurement. Measurements were statistically compared using
Microsoft Excel. Samples that had been mounted with the posterior surface facing the coverslip
were not used in the analyses.
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SUPPLEMENTAL TABLES
Table S2. Antibodies used in immunohistochemistry, Related to Figures 1 and 4-9
Antibody Supplier Dilution RRID, Reference or Comment
Rat anti-Elav, clone 7E8A10 Developmental Studies
Hybridoma Bank
1:200 RRID:AB_528218
Mouse anti-Repo clone 8D12 Developmental Studies
Hybridoma Bank
1:200 RRID:AB_528448
Rabbit anti-TH Merck Millipore #AB152 1:200 or 500 (see figure legends) RRID:AB_390204
Rabbit anti-GABA Sigma #A2052 1:200 (1:500 in some
experiments)
RRID:AB_477652
Mouse anti-ChAT, clone
ChAT4B1
Developmental Studies
Hybridoma Bank
1:100 RRID:AB_528122, Chou et al.,
2010
Rabbit anti-fluorescein Molecular Probes A-889 1:500 RRID:AB_221561
Rabbit anti-GFP Abcam #ab6556 1:1000 RRID:AB_305564
Mouse anti-GFP, clone 1G9 Developmental Studies
Hybridoma Bank
1:1000 (differs in some
experiments: see figure legends)
RRID:AB_2617420
Rat anti-RFP, clone 5F8 Chromotek #5F8-100 1:200 RRID:AB_2336064
Mouse anti-actin, JLA-20-S Developmental Studies
Hybridoma Bank
1:200 RRID:AB_528068, for Westerns
Rat anti-CD8, clone 5H10 ThermoFisher Scientific
MCD0800
1:200 RRID:AB_10392843
Rabbit anti-VGlut, affinity
purified
kind gift of Dr H. Aberle 1:500 RRID:AB_2315544, Mahr and
Aberle, 2006
Mouse anti-Futsch, clone 22C10 Developmental Studies
Hybridoma Bank
1:1000 RRID:AB_528403,
Hummel et al., 2000
Alexa 647 goat anti-rabbit ThermoFisher Scientific A21245 1:500 RRID:AB_2535813
Alexa 488 goat anti-rabbit ThermoFisher Scientific A11008 1:500 RRID:AB_143165
Alexa 647 goat anti-mouse ThermoFisher Scientific A21240 1:500 RRID:AB_2535809
Alexa 488 goat anti-mouse ThermoFisher Scientific A11001 1:500 RRID:AB_2534069
Alexa 594 goat anti-rabbit ThermoFisher Scientific A11012 1:500 RRID:AB_2534079
Alexa 594 goat anti-mouse ThermoFisher Scientific A11005 1:500 RRID:AB_2534073
Alexa 647 goat anti-rat ThermoFisher Scientific A21247 1:500 RRID:AB_141778
Alexa 568 goat anti-rat ThermoFisher Scientific A11077 1:500 RRID:AB_2534121
Alexa 568 goat ant-mouse ThermoFisher Scientific A11004 1:500 RRID:AB_2534072
Alexa 568 goat anti-rabbit ThermoFisher Scientific A11011 1:500 RRID:AB_143157
Alexa 488 goat anti-rat ThermoFisher Scientific A11006 1:500 RRID:AB_2534074
LEGENDS TO SUPPLEMENTAL FIGURES
Figure S1. Supplemental data on effects of pan-neuronal COX7A knockdown (COX
assembly, respirometry and apoptosis), Related to Figure 1
(A) Western blots of protein extracts (amounts loaded in the various gel tracks, as indicated, in
μg) from pooled heads of 30 male flies of each genotype shown: con (control) – elav-GAL4C155,
UAS-Dcr-2 / Y ; P{attP, y+, w3} / +, and KD (COX7A knockdown) – elav-GAL4C155, UAS-Dcr-
2 / Y ; UAS-RNAiCOX7A / +. Horizontally separated tracks are from different gels, probed with
antibodies as indicated in Transparent Methods; molecular weights (in kDa) of closest markers
run on same gels, following Ponceau S staining of the membranes, as shown. The samples in (i)
and (ii) represent two biological replicates. The extent of COX4 depletion was quantitated by
densitometry and normalized against α-actinin as a loading reference, giving a residual signal of
34% of the control value for experiment (i) and 48% for experiment (ii). The latter value may be
more reliable due to low signal intensities in (i). (B) Respirometry on extracts from pooled heads
of 50 male flies of each genotype shown: con (control) and elav-GAL4>COX7A KD as above,
normalized for protein content, using cI-, cIII- and cIV-linked substrate mixes. No error bars are
shown since this was a single large-scale experiment using fresh material. Replicate experiments
gave similar data. (C) TUNEL-staining of brain from elav-GAL4>COX7A KD male, prepared
on the day of eclosion, alongside a w1118 positive control brain (DNase I-treated). TUNEL stain
was amplified by immunohistochemistry (rabbit anti-fluorescein, followed by Alexa 488 goat
anti-rabbit, see Table S2). Scale bar 50 μm.
Figure S2. Supplemental data on effects of pan-neuronal COX7A knockdown (apoptotic
cells), Related to Figure 1
(A) Number of TUNEL-positive cells per brain (n = 10 for each class, as indicated). Boxplot
shows interquartile range (box), median (bold line), Tukey-style whiskers (Krzywinski and
Altman, 2014) and outliers (open circles). *** denotes significant difference (Student's t test, p <
0.001). Note that this experiment was performed on 21-day old flies not carrying UAS-Dcr-2, i.e.
the same control and knockdown genotypes as originally studied by Kemppainen et al. (2014)
and by Andjelković et al. (2015), showing a milder knockdown phenotype than when UAS-Dcr-2
is also present. (B) Immunocytochemistry for fluorescein (TUNEL) and nuclear markers for (i)
glia (Repo) and (ii) neurons (Elav) in single optical sections from two elav-GAL4>COX7A KD
knockdown brains (including UAS-Dcr-2). Scale bars 20 μm. Note that both classes of neural
cells were affected, even though the driver itself is active only in neurons.
Figures S3 and S4. Supplemental data on effects of pan-neuronal COX7A knockdown
(Apoliner), Related to Figure 1
Images of brains of elav-GAL4>COX7A KD males also expressing Apoliner (derived from the
cross UAS-RNAiCOX7A / + ; UAS-Apoliner / TM3, Sb males to elav-GAL4C155 ; UAS-Dcr-2 virgin
females), prepared on the day of eclosion. Genotypes were verified by PCR on residual
carcasses. GFP was detected by mouse anti-GFP primary antibody (1:2,000) and Alexa 488 goat
anti-mouse secondary antibody (1:500), and Elav by rat anti-Elav (1:200) and Alexa 647 goat
anti-rat secondary antibody (1:500). For full details of antibodies see Table S2. Images show
single optical sections at 2 μm resolution. Fig. S3A (high) and Fig. S4 (low) magnification
images, scale bars 20 μm and 100 μm, respectively. At highest magnification in Fig. S3B, one
cell in the population appears to show clear co-localization of GFP with the Elav neuronal
nuclear marker, although this may be an artifact due to low vertical resolution and high intensity
of the cytoplasmic signal. Scale bar 5 μm.
Figure S5. Supplemental data on effects of pan-neuronal COX7A knockdown (ROS),
Related to Figure 1
DHE staining of control and elav-GAL4>COX7A KD brains. Signal intensity on an arbitrary
scale is as indicated. Scale bars 100 μm.
Figure S6.  Counterstaining for Elav validates immunohistochemistry for TH, Related to
Figure 1
To check that the depletion of TH observed in COX7A KD brains was not due to differential
antibody penetration in different samples, brains of controls (genotype – elav-GAL4C155 / Y ;
UAS-Dcr-2 / P{attP,y+,w3´}) and elav-Gal4>COX7A KD flies (genotype – elav-Gal4C155 / Y;
UAS-Dcr-2 / UAS-RNAiCOX7A) were counterstained for Elav, a pan-neuronal nuclear marker, as
well as TH (1:1,000), as indicated. Zoomed images (scale bars 20 μm; optimized for overall
contrast and brightness but otherwise using same settings for controls and knockdown brains)
show variable relative signal within a class, but generally lower TH signals in knockdown brains,
as quantified in Fig. 1.
Figures S7, S8 and S9. Expression patterns produced by various neuronal GAL4 drivers
(TH-, Ddc-, TRH-GAL4), Related to Figure 2
Immunohistochemistry for GFP and the indicated markers (TH – 1:200, Elav, Chat, GABA), of
brains of flies expressing nuclear GFP (nGFP, 'Stinger') under the control of the indicated
drivers, at different magnifications, as indicated by the scale bars. Fig. S7 – maximum intensity
projection of (i, ii) brains of two flies expressing nGFP under the control of TH-GALl4. Scale
bars 100 μm. Fig. S8 – maximum intensity projection of (i, ii) brains of two flies expressing
nGFP under the control of Ddc-GAL4. Scale bars 100 μm. Fig. S9A – single optical section from
such a specimen, at higher magnification. Scale bar 10 μm.  Fig. S9B – maximum intensity
projection of brain of a fly expressing nGFP under the control of TRH-GAL4. Scale bar 100 μm.
Figure S10. Phenotypes produced by various neuronal GAL4 drivers, Related to Figure 2
(A) Locomotor impairment produced by COX7A knockdown using various drivers, as indicated,
measured 7 or 10 days after eclosion (two separate experiments separated by dashed line). Box-
plot nomenclature: boxes denote interquartile range (IQR), bold lines the median, with standard,
Tukey-style whiskers (Krzywinski and Altman, 2014). (B) Median lifespan (mean + SD, n = 5
except for controls, n = 4) of female flies in which COX7A was knocked down using the
indicated drivers. Horizontal lines indicate significant differences (one-way ANOVA with Tukey
post hoc HSD test, blue lines: p < 0.01, red lines: p < 0.05). Note that, based on these data,
effects of COX7A knockdown in DA neurons were not simply delayed, compared with other
neuronal classes. By 10 days of age (A), no effects on locomotor performance were seen and (B)
lifespan was only slightly affected, using either of the dopaminergic or the serotonergic drivers.
Figures S11, S12 and S13. Expression pattern produced by the Cha-GAL4 driver, Related
to Figure 2
Fig. S11A – low magnification images of a series of confocal planes, showing extensive overlap
between expressed nGFP, driven by Cha-GAL4, and Elav, a pan-neuronal marker. Scale bar 100
μm. Fig. S11B – high magnification image (single optical section) showing the wide quantitative
variation in GFP signal between neuronal nuclei, indicative of varying expression using the Cha-
GAL4 driver. Intensity of staining arbitrarily indicated numerically as 1-5, in increasing
intensity. Scale bar 5 μm. Fig. S11C – high magnification image (single optical section) showing
that most nGFP-positive cells using the Cha-GAL4 driver are also positive for ChAT (choline
acteyltransferase), but in many cases at very low levels. Scale bar 5 μm. Fig. S12 – maximum
intensity projection of whole brain of a fly expressing nGFP under the control of Cha-Gal4.
Scale bar 100 μm. Fig. S13A – high magnification image (single optical section) confirming that
some nGFP-positive cells using the Cha-GAL4 driver are also positive for TH. Scale bar 10 μm.
Fig. S13B – high magnification image (single optical section) showing that some GFP-positive
cells are also positive for GABA. Note that, in many cell bodies, the GABA antibody stains
mainly the nucleus. Scale bar 20 μm. Thus, in line with Lucin et al. (2019), the Cha-GAL4 driver
is not 100% specific for cholinergic neurons.
Figure S14. Expression patterns produced by the OK371  driver, Related to Figure 2
Maximum intensity projection of the brain from a fly expressing nGFP under the control of
OK371, immunostained for GFP and Elav, as shown. Scale bar 100 μm.
Figures S15, S16 and S17. Expression driven by R55A05 is confined to cholinergic neurons,
Related to Figures 3 and 4
Immunohistochemistry of brains from 5-day old male flies expressing various reporters under
the control of the R55A05 GAL4 driver. Fig. S15 – maximum intensity projection of the whole
brain stained for CD8 (genotype: R55A05-GAL4 / UAS-mCD8::GFP). For a single optical
section of an equivalent brain co-stained for CD8 and ChAT, see Fig. 3A. Scale bar 50 μm. Fig.
S16A, S16B, S17A and S17B – maximum intensity projections of whole brains stained for
(nuclear) GFP and the neural markers indicated: Fig. S16 – GABA, as a marker for GABAergic
neurons, Fig. S17A – TH (1:200), as a marker for DA neurons, and Fig. S17B – Repo, as a
marker for glial cells. Genotype: UAS-Stinger / + ; R55A05-GAL4 / +. Scale bars: 100 μm,
except Fig. S17B – 50 μm.
Figures S18, S19 and S20. R59E04 drives expression in a subset of cholinergic, but not DA
neurons, Related to Figures 3 and 4
Fig. S18 – reference images showing expression patterns using R55A05 and R54E09 GAL4
drivers (Jenett et al., 2012), in the brain and ventral nerve cord as indicated – publicly available
images generated by the Janelia FlyLight Project Team and the laboratories of Gerald M. Rubin,
James W. Truman, Richard S. Mann, and Christopher Q. Doe, reproduced under Creative
Commons Licence (CC BY 4.0). See also https://www.janelia.org/open-science/janelia-flylight-
expression-patterns-gal4-and-lexa-driver-lines. Scale bars 100 μm, GFP and Bruchpilot
(background control) signals as indicated. Fig. S19 – zoomed immunohistochemistry images
from bottom panel of Fig. 4C: maximum projection image of three brain regions (i-iii) from a fly
expressing (membrane-bound) mCD8-GFP under the control of the R59E04 GAL4 driver, co-
stained for GFP and ChAT. Scale bars 20 μm. Fig. S20 – immunohistochemistry of brain from a
5-day old male fly expressing nuclear GFP under the control of the R59E04 GAL4 driver
(genotype: UAS-Stinger / + ; R59E04-GAL4 / +). Maximum intensity projection co-stained for
GFP and for TH (1:200). Scale bar100 μm. Note that the discontinuity in the image in Fig. S20 is
due to separate acquisition of the z-stacks using a relatively aged microscope that does not
digitally smooth out such boundaries when stacks are combined.
Figure S21. R51C09 does not drive expression in GABAergic or DA neurons, Related to
Figure 5
Immunohistochemistry of brains from 5-day old male flies expressing nuclear GFP under the
control of the R51C09 GAL4 driver (genotype: UAS-Stinger / + ; R51C09-GAL4 / +). Maximum
intensity projection of the whole brain stained for GFP and for (A) GABA and (B) TH (1:500).
Scale bars 100 μm. Note that the reporter used here (Stinger, nuclear GFP) enables colocalization
to be visualized more reliably (green nuclei surrounded by magenta cytoplasm, rather than white
areas which could arise from signals in different cells not resolved by the optics). The GFP
reporter used in Fig. 5 is the membrane bound (mCD8) version, which prominently labels
projections in the optic lobe, whereas the nuclear GFP does not.
Figure S22. R52A01 does not drive expression in GABAergic or DA neurons, Related to
Figure 6
Immunohistochemistry of brains from 5-day old male flies expressing nuclear GFP under the
control of the R52A01 GAL4 driver (genotype: UAS-Stinger / + ; R52A01-GAL4 / +). Maximum
intensity projection of the whole brain stained for GFP and for (A) GABA and (B) TH (1:500).
Scale bars 100 μm. Note that the reporter used here (Stinger, nuclear GFP) enables colocalization
to be visualized more reliably (green nuclei surrounded by magenta cytoplasm, rather than white
areas which could arise from signals in different cells not resolved by the optics). The GFP
reporter used in Fig. 6 is the membrane bound (mCD8) version, which prominently labels
projections in the optic lobe, whereas the nuclear GFP does not.
Figure S23. Minimal overlap of expression directed by cholinergic drivers R55A05 and
R59E04, Related to Figures 4-6
(A) Maximum intensity projection, (B) zoomed substack from (A) and (C, D) single optical
sections from brain from a female fly co-expressing GFP (green) under the control of driver
R59E04 and RFP (magenta) under the control of R55A05, using the LexA and GAL4 expression
systems, respectively. Genotype was 10XUAS-IVS-mCD8::RFP, 13XLexAop2-mCD8::GFP / + ;
R59E04-lexA / + ; R55A05-GAL4 /+. Scale bars (A) 100 μm, (B, C, D) 20 μm. Note the almost
total lack of overlap, even for brain regions where neurites targeted by each driver intermingle,
as in (B). In a small number of specific brain regions, e.g., in (C), there is overlap of the signals,
whereas in most of the brain, e.g., in (D), they are completely separate.
Figure S24. Minimal overlap of expression directed by glutamatergic drivers R52A01 and
R51C09, Related to Figures 4-6
(A) Maximum intensity projection, (B) single optical section and (C) zoomed area from (B) of
brain from a female fly co-expressing GFP (green) under the control of driver R52A01 and RFP
(magenta) under the control of R51C09, using the LexA and GAL4 expression systems,
respectively. Genotype was 10XUAS-IVS-mCD8::RFP, 13XLexAop2-mCD8::GFP / + ; R52A01-
lexA / + ; R51C09-GAL4 /+. Scale bars (A, B) 100 μm, (C) 20 μm. Note specific brain structures
in (C), where both reporters are expressed, indicating a small degree of overlap between the
drivers. See also images from the FlyLight collection at:
http://flweb.janelia.org/cgi-bin/view_flew_imagery.cgi?line=R51C09 and
http://flweb.janelia.org/cgi-bin/view_flew_imagery.cgi?line=R52A01.
Figures S25 through S31. Brain regions where DA neurons and R55A05 (or R59E04)
neurons project show a small degree of overlap, Related to Figure 7
Fig. S25 and S26 – immunohistochemistry for TH (1:200, green) and CD8 (magenta) of brains
from male fly expressing mCD8-Cherry under the control of Fig. S25 – R55A05 and Fig. S26 –
R59E04. Genotypes – R55A05-GAL4 (or R59E04-GAL4) / UAS-mCD8::Cherry. Maximum
projection images of the whole brain (scale bar 100 μm), with zoomed areas as indicated. Fig.
S27, S28 and S29 – individual TH and RFP signals from optical sections of the brain analyzed in
Fig. 7, showing minimal overlap between (TH-positive) DA neurons and neurons post-
synaptically expressing RFP under the control of trans-Tango, driven by R55A05. Scale bars 10
μm. Panel numbers correspond with those of Fig. 7. The clusters of neurons intensely stained for
TH (panels ii, iii, and v) are negative for RFP, whilst the cell-bodies of a few neurons staining
intensely for RFP are essentially negative for TH (panel vii). A few neurites are stained for both
markers, as shown by the small minority of signals that overlap (panels x and xii). Fig. S30 and
S31 – optical sections of the brain analyzed in Fig. 7, showing the location of the DA neuron
clusters visualized in panels i-v thereof. Scale bars in zoomed images 10 μm.
Figures S32 through S39. TH deficiency in subsets of neurons with COX7A knockdown,
Related to Figures 8 and 9
Immunohistochemistry for TH (1:1,000) and Elav in brains from flies with COX7A knockdown
or controls with only Dcr-2 overexpression, as indicated, using the GAL4 drivers shown
(maximum intensity projections). Individual specimens also shown in Fig. 8 or 9 (TH only)
indicated by *. Genotypes – Dcr-2 only:  + ; R55A05-GAL4 (or R59E04-GAL4, or R52A01-
GAL4 or R51C09-GAL4) / UAS-Dcr-2, COX7A-KD: UAS-RNAiCOX7A / + ; R55A05-GAL4 (or
R59E04-GAL4, or R52A01-GAL4 or R51C09-GAL4) / UAS-Dcr-2. Scale bars 100 μm. Contrast
and brightness have been similarly adjusted in each image, giving uniform background
fluorescence.  Sample variation and the subtle nature of the observed differences preclude
reliable quantitation.
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